160 related articles for article (PubMed ID: 20594864)
1. Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer.
Tu Z; Xu J; Jones LA; Li S; Zeng D; Kung MP; Kung HF; Mach RH
Appl Radiat Isot; 2010 Dec; 68(12):2268-73. PubMed ID: 20594864
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.
Tu Z; Xu J; Jones LA; Li S; Dumstorff C; Vangveravong S; Chen DL; Wheeler KT; Welch MJ; Mach RH
J Med Chem; 2007 Jul; 50(14):3194-204. PubMed ID: 17579383
[TBL] [Abstract][Full Text] [Related]
3. Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors.
Abate C; Selivanova SV; Müller A; Krämer SD; Schibli R; Marottoli R; Perrone R; Berardi F; Niso M; Ametamey SM
Eur J Med Chem; 2013 Nov; 69():920-30. PubMed ID: 24161678
[TBL] [Abstract][Full Text] [Related]
4. Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant
Moldovan RP; Gündel D; Teodoro R; Ludwig FA; Fischer S; Toussaint M; Schepmann D; Wünsch B; Brust P; Deuther-Conrad W
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064122
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
6. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands.
Rowland DJ; Tu Z; Xu J; Ponde D; Mach RH; Welch MJ
J Nucl Med; 2006 Jun; 47(6):1041-8. PubMed ID: 16741315
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
9. New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.
Chu W; Xu J; Zhou D; Zhang F; Jones LA; Wheeler KT; Mach RH
Bioorg Med Chem; 2009 Feb; 17(3):1222-31. PubMed ID: 19119012
[TBL] [Abstract][Full Text] [Related]
10. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer.
Tu Z; Dence CS; Ponde DE; Jones L; Wheeler KT; Welch MJ; Mach RH
Nucl Med Biol; 2005 Jul; 32(5):423-30. PubMed ID: 15982571
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies.
Staelens L; Oltenfreiter R; Dumont F; Waterhouse RN; Vandenbulcke K; Blanckaert P; Dierckx RA; Slegers G
Nucl Med Biol; 2005 Feb; 32(2):193-200. PubMed ID: 15721765
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):470-5. PubMed ID: 16595947
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent.
Moussa IA; Banister SD; Giboureau N; Meikle SR; Kassiou M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6820-3. PubMed ID: 21962578
[TBL] [Abstract][Full Text] [Related]
16. Design, development and bio-evaluation of a novel radio-ligand
Chaudhary V; Chaturvedi S; Wadhwa A; Chaudhary R; Gautam D; Sharma D; Kumar R; Mishra AK
Bioorg Med Chem; 2024 Jan; 97():117515. PubMed ID: 38043245
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
18. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
